---
title: 'A Systematic Review on Prostate-Specific Membrane Antigen Positron Emission
  Tomography (PSMA PET) Evaluating Localized Low- to Intermediate-Risk Prostate Cancer:
  A Tool to Improve Risk Stratification for Active Surveillance?'
date: '2024-01-23'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38255691/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240123170741&v=2.18.0
source: heidelberg[Affiliation]
description: Active surveillance remains a treatment option for low- to intermediate-risk
  prostate cancer (PCa) patients. Prostate-specific membrane antigen positron emission
  tomography and computed tomography (PSMA PET/CT) has emerged as a useful modality
  to assess intraprostatic lesions. This systematic review aims to evaluate PSMA PET/CT
  in localized low- to intermediate-risk PCa to determine its role in active surveillance.
  Following PRISMA guidelines, a search was performed on Medline, Embase, ...
disable_comments: true
---
Active surveillance remains a treatment option for low- to intermediate-risk prostate cancer (PCa) patients. Prostate-specific membrane antigen positron emission tomography and computed tomography (PSMA PET/CT) has emerged as a useful modality to assess intraprostatic lesions. This systematic review aims to evaluate PSMA PET/CT in localized low- to intermediate-risk PCa to determine its role in active surveillance. Following PRISMA guidelines, a search was performed on Medline, Embase, ...